Skip to main content
. 2021 Oct 15;11:20531. doi: 10.1038/s41598-021-00085-0

Figure 5.

Figure 5

Cytotoxicity evaluation of the nanostructures. EPG85.257-RDB and HeLa-RDB viability after 72 h incubation with nanoparticle-free media (a), MSN (b), NH2-MSN(c), MSN-CS(d), MSN-CS-PEG-folate (e), MSN-CS-PEG-TAT (f), and MSN-CS-PEG-folate/TAT (g). Nanoparticles were found to be biocompatible, and the treatment concentration should not exceed 100 μg/ml. Data showed that nanoparticles were biocompatible, and the treatment concentration should not be exceeded 100 μg/ml. *p < 0.05 denote significant differences between the control and treatment samples according to the one-way ANOVA (non-parametric Kruskal–Wallis analyses). CS Chitosan, PEG polyethylene glycol, TAT trans-activator of transcription.